BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1724932)

  • 1. Heredopathia atactica polyneuritiformis (Refsum's disease).
    Cervós-Navarro J
    Histol Histopathol; 1990 Oct; 5(4):439-50. PubMed ID: 1724932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Refsum syndrome, heredopathia atactica polyneuritiformis in the view of the otolaryngologist (author's transl)].
    Feldmann H
    Laryngol Rhinol Otol (Stuttg); 1981 May; 60(5):235-40. PubMed ID: 6164893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heredopathia atactica polyneuritiformis. Hexadecanoic acid storage disease (Refsum's disease). Definition, treatment and pathogenesis. A short review].
    Refsum S
    Psychiatr Neurol Med Psychol Beih; 1977; 22-23():11-8. PubMed ID: 95656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of phytanic acid on cultured retinal pigment epithelium: an in vitro model for Refsum's disease.
    Bernstein PS; Lloyd MB; O'Day WT; Bok D
    Exp Eye Res; 1992 Dec; 55(6):869-78. PubMed ID: 1283128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Refsum's disease: evolution 35 years after diagnosis].
    Marcaud V; Defontaines B; Jung P; Degos CF
    Rev Neurol (Paris); 2002 Feb; 158(2):225-9. PubMed ID: 11965181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heredopathia atactica polyneuritiformis: phytanic acid storage disease (Refsum's syndrome). Effect of diet therapy on retinal and cochlear changes].
    Refsum S
    Neurol Neurochir Pol; 1984; 18(1):1-4. PubMed ID: 6203044
    [No Abstract]   [Full Text] [Related]  

  • 7. Heredopathia atactica polyneurotiformis: therapeutic and pathogenetic aspects.
    Refsum S
    Riv Patol Nerv Ment; 1976 Jun; 97(3):115-26. PubMed ID: 74082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refsum's disease. A unique case.
    Jaffe DF; Crezee KS; Mason S; Leavens-Chiarelli T; Lawrence W
    J Am Podiatr Med Assoc; 1998 Aug; 88(8):406-9. PubMed ID: 9735628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation.
    Wierzbicki AS; Lloyd MD; Schofield CJ; Feher MD; Gibberd FB
    J Neurochem; 2002 Mar; 80(5):727-35. PubMed ID: 11948235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phytanic-acid storage disease: Refsum's syndrome. Heredopathia atactica polyneuritiformis].
    Atzpodien W; Thümler R; Kremer GJ
    Dtsch Med Wochenschr; 1977 Oct; 102(41):1480-4. PubMed ID: 71983
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatty acid composition of tissues in Refsum's disease (herodopathia atactica polyneuritiformis). Estimation of total phytanic acid accumulation.
    Malmendier CL; Jonniaux G; Voet W; Van Den Bergen CJ
    Biomedicine; 1974 Nov; 20(6):398-407. PubMed ID: 4141904
    [No Abstract]   [Full Text] [Related]  

  • 12. [Refsum's syndrome (author's transl)].
    Thümler R; Atzpodien W; Kremer GJ; Haferkamp G
    Dtsch Med Wochenschr; 1977 Oct; 102(41):1454-7. PubMed ID: 71982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heredopathia atactica polyneuritiformis phytanic-acid storage disease, Refsum's disease:" a biochemically well-defined disease with a specific dietary treatment.
    Refsum S
    Arch Neurol; 1981 Oct; 38(10):605-6. PubMed ID: 6170281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of plasma phytanic acid levels in adults.
    Britton TC; Gibberd FB; Clemens ME; Billimoria JD; Sidey MC
    J Neurol Neurosurg Psychiatry; 1989 Jul; 52(7):891-4. PubMed ID: 2475586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infantile Refsum's disease: a peroxisomal storage disorder?
    Manson JI; Pollard AC; Poulos A; Carter RF
    Clin Exp Neurol; 1985; 21():283-7. PubMed ID: 2436838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of patients with retinitis pigmentosa for heredopathia atactica polyneuritiformis (Refsum's disease).
    Goldman JM; Clemens ME; Gibberd FB; Billimoria JD
    Br Med J (Clin Res Ed); 1985 Apr; 290(6475):1109-10. PubMed ID: 2580589
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and biochemical follow up of Refsum's disease (author's transl)].
    Barolin GS; Hodkewitsch E; Höfinger E; Scholz H; Bernheimer H; Molzer B
    Fortschr Neurol Psychiatr Grenzgeb; 1979 Feb; 47(2):53-66. PubMed ID: 84779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refsum's disease may mimic familial Guillain Barre syndrome.
    Verny C; Prundean A; Nicolas G; Pautot V; Maugin D; Levade T; Bonneau D; Dubas F
    Neuromuscul Disord; 2006 Nov; 16(11):805-8. PubMed ID: 16934464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heredopathia atactica polyneuritiformis (Refsum's Disease): a second trial of dietary therapy in two patients.
    Kark RA; Engel WK; Blass JP; Steinberg D; Walsh GO
    Birth Defects Orig Artic Ser; 1971 Feb; 7(1):53-5. PubMed ID: 4141911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term strategies for the treatment of Refsum's disease using therapeutic apheresis.
    Zolotov D; Wagner S; Kalb K; Bunia J; Heibges A; Klingel R
    J Clin Apher; 2012; 27(2):99-105. PubMed ID: 22267052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.